Harry Thomasian Jr. - 23 May 2026 Form 4 Insider Report for PRECIGEN, INC. (PGEN)

Reporting relationship: Chief Financial Officer
Issuer ticker: PGEN
Reported as of: 23 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 27 May 2026, 20:26:26 UTC
Prior SEC filing: 22 Apr 2026
Next SEC filing: 01 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Harry Thomasian, Jr., by Donald P. Lehr, as attorney-in-fact

Key filing fact

Harry Thomasian Jr. filed Form 4 for PRECIGEN, INC. (PGEN) on 27 May 2026.

Key facts

This page summarizes Harry Thomasian Jr.'s Form 4 filing for PRECIGEN, INC. (PGEN).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 27 May 2026, 20:26.

Change

Previous filing in this sequence was filed on 22 Apr 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001886301 Primary reporting owner

Thomasian Harry Jr.

Relationship: Chief Financial Officer
Address: 20374 SENECA MEADOWS PARKWAY, GERMANTOWN
Signature: /s/ Harry Thomasian, Jr., by Donald P. Lehr, as attorney-in-fact
Signature date: 27 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PGEN transaction

Common Stock

Options Exercise

Transaction value
Shares: +87,500
Change %: +17%
Price
Shares after: 596,419
Date: 23 May 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PGEN transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares: -87,500
Change %: -50%
Price: $0.000000^*
Shares after: 87,500
Date: 23 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 87,500
Exercise price
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.

Footnote F2

Represents 50% of the RSUs granted on June 26, 2025 that vested on May 23, 2026. The remaining RSUs will vest in equal quarterly installments for three years thereafter.